Canada’s patent ‘utility’ regime on trial: Adrienne Blanchard for the MLI IP newsletter
The Supreme Court’s decision to hear AstraZeneca’s appeal and this month’s NAFTA hearings on an Eli Lilly complaint shine a ...
The Supreme Court’s decision to hear AstraZeneca’s appeal and this month’s NAFTA hearings on an Eli Lilly complaint shine a ...
While there was certainly a win on the costs of genetic testing, the long-term effects of Transgenomic’s departure from the ...
It has become fashionable to declare the Trans-Pacific Partnership intellectual property provisions a disaster for innovation in Canada, writes Richard ...
|
Thank you for Signing Up |
323 Chapel Street, Suite #300
Ottawa, Ontario, K1N 7Z2 Canada
613.482.8327
Support the Macdonald-Laurier Institute to help ensure that Canada is one of the best governed countries in the world. Click below to learn more or become a sponsor.
© 2023 Macdonald-Laurier Institute. All Rights reserved.